Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures (SAP) Purchase Order for Supply Chain Monitoring – Infant Formula

The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed-price commercial service contract to Circana, LLC for the Purchase of Supply Chain Monitoring – Infant Formula. The contract aims to support the continuity of the FDA's monitoring of the infant formula supply chain due to the U.S. infant formula shortage initiative. The deliverables include an Out of Stock Tracking Solution (OOS) with 2 user licenses and Liquid Data Go (LDG) with 1 user license, both with an estimated delivery date of July 30, 2026, and valid for 1 year. • The contract will be awarded using simplified acquisition procedures in accordance with FAR RFO Part 12 for the acquisition of commercial products and commercial services. • The North American Industry Classification System (NAICS) code for the proposed acquisition is 541910 - Marketing Research and Public Opinion Polling. • Responses to this notice should be sent to Haroon Gulzar at [email protected] no later than 5:00 pm (ET) on July 10, 2026.